Also trades as: TVGN (NASDAQ) · $vol 0M
TVGNW NASDAQ
Tevogen Bio Holdings Inc.
1W: -5.7%
1M: +16.8%
3M: +7.9%
YTD: +46.3%
1Y: +12.7%
$0.06
+0.00 (+1.32%)
Weekly Expected Move ±14.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$12.7M
52W Range0.0253-0.075
Volume306,945
Avg Volume167,880
Beta0.22
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORyan H. Saadi
Employees18
SectorHealthcare
IndustryBiotechnology
IPO Date2024-02-15
Websitetevogen.com
15 Independence Blvd
Warren, NJ 07059
US
Warren, NJ 07059
US
877 838 6436
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company focused on developing ready-to-use, precision T cell therapies. Their research and development efforts span virology, oncology, and neurological conditions. The company's flagship experimental treatment, TVGN 489, is a precision T cell product designed to meet the unmet needs of individuals severely affected by acute COVID-19, as well as a specific group of patients struggling with long COVID. Tevogen Bio Holdings Inc. is headquartered in Warren, New Jersey.
Latest News
Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Short Interest Update
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
Tevogen Bio (NASDAQ:TVGN) Shares Down 5.9% – Here’s What Happened
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Saadi Ryan H. | G-Gift | 50,000 | — | 2025-12-18 |
| Desai Kirti | G-Gift | 300,000 | — | 2025-12-11 |
| Saadi Ryan H. | G-Gift | 460,000 | — | 2025-12-11 |
| Saadi Ryan H. | G-Gift | 20,000 | — | 2025-08-15 |
| Saadi Ryan H. | A-Award | 8,000,000 | — | 2025-06-27 |